Sharon H. Giordano, M.D., MPH, FASCO

Peer-Reviewed Articles

1. Huepenbecker SP, Fu S, Sun CC, Zhao H, Primm KM, Giordano SH, Meyer LA. Medicaid expansion and 2-year survival in women with gynecologic cancer: a difference-in-difference analysis. Am J Obstet Gynecol 227(3):482.e1-482.e15, 2022. e-Pub 2022. PMID: 35500609.
2. Giordano SH, Franzoi MAB, Temin S, Anders CK, Chandarlapaty S, Crews JR, Kirshner JJ, Krop IE, Lin NU, Morikawa A, Patt DA, Perlmutter J, Ramakrishna N, Davidson NE. Systemic therapy for advanced human epidermal growth factor receptor 2-positive breast cancer: ASCO guideline update. J Clin Oncol 40(23):JCO2200519, 2022. e-Pub 2022. PMID: 35640077.
3. Ramakrishna N, Anders CK, Lin NU, Morikawa A, Temin S, Chandarlapaty S, Crews JR, Davidson NE, Franzoi MAB, Kirshner JJ, Krop IE, Patt DA, Perlmutter J, Giordano SH. Management of advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: ASCO guideline update. J Clin Oncol 40(23):JCO2200520, 2022. e-Pub 2022. PMID: 35640075.
4. Garner DC, Niu J, Stender CF, Hinkston CL, Giordano SH, Wehner MR. Association between obesity and sunburn diagnoses: a cross-sectional analysis in a large claims dataset. J Invest Dermatol 142(7):2034-2036, 2022. e-Pub 2021. PMID: 34843680.
5. Huepenbecker SP, Sun CC, Fu S, Zhao H, He W, Primm K, Giordano SH, Meyer LA. Temporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States. Int J Gynecol Cancer 32(7):899-905, 2022. e-Pub 2022. PMID: 35331992.
6. Freedman RA, Graff SL, Somerfield MR, Telli ML, Wolff AC, Giordano SH. Adjuvant abemaciclib plus endocrine therapy in the treatment of high-risk early breast cancer: ASCO guideline rapid recommendation update q and a. JCO Oncol Pract 18(7):OP2200140, 2022. e-Pub 2022. PMID: 35377771.
7. Corrigan KL, Fu S, Chen YS, Kaiser K, Roth M, Peterson SK, Shih YT, Jagsi R, Giordano SH, Volk RJ, Yabroff KR, Banegas MP, Acquati C, Conti RM, Ma HY, Ku K, You YN, Smith GL. Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery. Cancer 128(13):2455-2462, 2022. e-Pub 2022. PMID: 35417565.
8. Lu Z, Zhang N, Giordano SH, Zhao H. Opioid use and associated factors among pancreatic cancer patients diagnosed between 2007 and 2015. Cancer Med 11(11):2296-2307, 2022. e-Pub 2022. PMID: 35199472.
9. Bruera S, Lei X, Blau B, Zhao H, Deswal A, Yazdany J, Giordano SH, Suarez-Almazor ME. Postoperative major adverse cardiac events in patients with systemic lupus erythematosus. ACR Open Rheumatol 4(6):511-519, 2022. e-Pub 2022. PMID: 35294107.
10. Malinowski C, Lei X, Zhao H, Giordano SH, Chavez-MacGregor M. Association of medicaid expansion with mortality disparity by race and ethnicity among patients with de novo stage IV breast cancer. JAMA Oncol 8(6):863-870, 2022. e-Pub 2022. PMID: 35389432.
11. Polychronopoulou E, Giordano SH, Chou LN, Yu X, Kuo YF. Signal detection of adverse events associated with trastuzumab in a cohort of elderly patients with breast cancer. Oncologist 27(6):434-440, 2022. e-Pub 2022. PMID: 35438771.
12. Suarez-Almazor ME, Pundole X, Cabanillas G, Lei X, Zhao H, Elting LS, Lopez-Olivo MA, Giordano SH. Association of bone mineral density testing with risk of major osteoporotic fractures among older men receiving androgen deprivation therapy to treat localized or regional prostate cancer. JAMA Netw Open 5(4):e225432, 2022. e-Pub 2022. PMID: 35363269.
13. Karuturi MS, Giordano SH, Hoover DS, Volk RJ, Housten AJ. Exploring and supporting older women's chemotherapy decision-making in early-stage breast cancer. J Geriatr Oncol 13(2):170-175, 2022. e-Pub 2021. PMID: 34955445.
14. Huepenbecker SP, Zhao H, Sun CC, Fu S, He W, Giordano SH, Meyer LA. Algorithm to identify incident epithelial ovarian cancer cases using claims data. JCO Clin Cancer Inform 6:e2100187, 2022. PMID: 35297648.
15. Sosa A, Lei X, Woodward WA, Chavez Mac Gregor M, Lucci A, Giordano SH, Nead KT. Trends in sentinel lymph node biopsies in patients with inflammatory breast cancer in the US. JAMA Netw Open 5(2):e2148021, 2022. e-Pub 2022. PMID: 35147686.
16. Oke O, Niu J, Chavez-MacGregor M, Zhao H, Giordano SH. Adjuvant tamoxifen adherence in men with early-stage breast cancer. Cancer 128(1):59-64, 2022. e-Pub 2021. PMID: 34597415.
17. Chavez-MacGregor M, Lei X, Zhao H, Scheet P, Giordano SH. Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer. JAMA Oncol 8(1):69-78, 2022. e-Pub 2021. PMID: 34709356.
18. Nitecki R, Fu S, Jorgensen KA, Gray L, Lefkowits C, Smith BD, Meyer LA, Melamed A, Giordano SH, Ramirez PT, Rauh-Hain JA. Employment disruption among women with gynecologic cancers. Int J Gynecol Cancer 32(1):69-78, 2022. e-Pub 2021. PMID: 34785522.
19. Giordano SH, Freedman RA, Somerfield MR, Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Expert Panel. Abemaciclib with endocrine therapy in the treatment of high-risk early breast cancer: ASCO optimal adjuvant chemotherapy and targeted therapy guideline rapid recommendation update. J Clin Oncol 40(3):JCO2102677, 2022. e-Pub 2021. PMID: 34878801.
20. Bruera S, Lei X, Zogala R, Pundole X, Zhao H, Giordano SH, Hwang JP, Rauh-Hain JA, Suarez-Almazor ME. Cervical cancer screening in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 73(12):1796-1803, 2021. e-Pub 2021. PMID: 32799430.
21. Maldonado JA, Fu S, Chen YS, Acquati C, Yabroff KR, Banegas MP, Chang S, Conti RM, Checka CM, Peterson SK, Advani P, Ku K, Jagsi R, Giordano SH, Volk RJ, Shih YT, Smith GL. Sensitivity of psychosocial distress screening to identify cancer patients at risk for financial hardship during care delivery. JCO Oncol Pract 17(12):OP2001009, 2021. e-Pub 2021. PMID: 34043452.
22. Wehner MR, Niu J, Wheless L, Baker LX, Cohen OG, Margolis DJ, Giordano SH, Shin TM. Risks of multiple skin cancers in organ transplant recipients: A cohort study in 2 administrative data sets. JAMA Dermatol 157(12):1447-1455, 2021. e-Pub 2021. PMID: 34668933.
23. Carmack CL, Parker NH, Demark-Wahnefried W, Shely L, Baum G, Yuan Y, Giordano SH, Rodriguez-Bigas M, Pettaway C, Basen-Engquist K. Healthy moves to improve lifestyle behaviors of cancer survivors and their spouses: Feasibility and preliminary results of intervention efficacy. Nutrients 13(12), 2021. e-Pub 2021. PMID: 34960013.
24. Nowakowska MK, Lei X, Wehner MR, Corn PG, Giordano SH, Nead KT. Association of second-generation antiandrogens with depression among patients with prostate cancer. JAMA Netw Open 4(12):e2140803, 2021. e-Pub 2021. PMID: 34940861.
25. Brown AM, Li Y, Hinkston CL, Giordano SH, Wehner MR. Use of indoor tanning diagnosis codes in claims data. JID Innov 1(4):100048, 2021. e-Pub 2021. PMID: 34909745.
26. Nowakowska MK, Lei X, Thompson MT, Shaitelman SF, Wehner MR, Woodward WA, Giordano SH, Nead KT. Association of statin use with clinical outcomes in patients with triple negative breast cancer. Cancer 127(22):4142-4150, 2021. e-Pub 2021. PMID: 34342892.
27. Huepenbecker SP, Sun CC, Fu S, Zhao H, Primm K, Giordano SH, Meyer LA. Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States. Cancer 127(22):4151-4160, 2021. e-Pub 2021. PMID: 34347287.
28. Swanick CW, Jiang J, Maldonado JA, Lei X, Shih YT, Caudle AS, Baumann DP, Giordano SH, Shaitelman SF, Shirvani SM, Smith BD. Differences in time burden across local therapy strategies for early-stage breast cancer. Plast Reconstr Surg Glob Open 9(11):e3904, 2021. e-Pub 2021. PMID: 34745797.
29. Karpes Matusevich AR, Duan Z, Zhao H, Lal LS, Chan W, Suarez-Almazor ME, Giordano SH, Swint JM, Lopez-Olivo MA. Treatment sequences after discontinuing a tumor necrosis factor inhibitor in patients with rheumatoid arthritis. A comparison of cycling versus swapping strategies. Arthritis Care Res (Hoboken) 73(10):1461-1469, 2021. e-Pub 2021. PMID: 32558339.
30. Nead KT, Hinkston CL, Linos E, Giordano SH, Wehner MR. American board of medical specialties board examination lactation accommodation policies. JAMA Intern Med 181(10):1397-1399, 2021. PMID: 34180945.
31. Nitecki R, Floyd J, Lamiman K, Clapp MA, Fu S, Jorgensen K, Melamed A, Brady PC, Kaimal A, Del Carmen MG, Woodard TL, Meyer LA, Giordano SH, Ramirez PT, Rauh-Hain JA. Outcomes of the first pregnancy after fertility-sparing surgery for early-stage cervical cancer. Obstet Gynecol 138(4):565-573, 2021. PMID: 34623068.
32. Nowakowska MK, Li Y, Garner DC, Stender CF, Hinkston CL, Giordano SH, Wehner MR. Clinical settings and demographic characteristics of patients with sunburn. JAMA Dermatol 157(9):1122-1125, 2021. e-Pub 2021. PMID: 34379105.
33. Bruera S, Lei X, Pundole X, Zhao H, Giordano SH, Vinod S, Suarez-Almazor ME. Systemic lupus erythematosus is a risk factor for mortality in elderly patients with early breast cancer. Arthritis Care Res (Hoboken). e-Pub 2021. PMID: 34558796.
34. Tamirisa N, Lei X, Caudle AS, Giordano SH, Zhao H, Chavez-MacGregor M. Impact of SSO-ASTRO "no ink on tumor" guidelines on reexcision rates among older breast cancer patients. Ann Surg Oncol 28(7):3703-3713, 2021. e-Pub 2020. PMID: 33225394.
35. Harrison RF, Fu S, Sun CC, Zhao H, Lu KH, Giordano SH, Meyer LA. Patient cost-sharing during poly(ADP-ribose) polymerase inhibitor treatment in ovarian cancer. Am J Obstet Gynecol 225(1):68.e1-68.e11, 2021. e-Pub 2021. PMID: 33549538.
36. Tamirisa N, Lin H, Shen Y, Shaitelman SF, Karuturi MS, Giordano SH, Babiera GV, Bedrosian I. Impact of adjuvant endocrine therapy in older patients with comorbidities and estrogen receptor-positive, node-negative breast cancer-a National Cancer Database analysis. Cancer 127(13):2196-2203, 2021. e-Pub 2021. PMID: 33735487.
37. Bayani J, Poncet C, Crozier C, Neven A, Piper T, Cunningham C, Sobol M, Aebi S, Benstead K, Bogler O, Dal Lago L, Fraser J, Hilbers F, Hedenfalk I, Korde L, Linderholm B, Martens J, Middleton L, Murray M, Kelly C, Nilsson C, Nowaczyk M, Peeters S, Peric A, Porter P, Schröder C, Rubio IT, Ruddy KJ, van Asperen C, Van Den Weyngaert D, van Deurzen C, van Leeuwen-Stok E, Vermeij J, Winer E, Giordano SH, Cardoso F, Bartlett JMS. Evaluation of multiple transcriptomic gene risk signatures in male breast cancer. NPJ Breast Cancer 7(1):98, 2021. e-Pub 2021. PMID: 34312396.
38. Zhao H, Lei X, Niu J, Zhang N, Duan Z, Chavez-MacGregor M, Giordano SH. Prescription patterns, initiation, and 5-year adherence to adjuvant hormonal therapy among commercially insured patients with breast cancer. JCO Oncol Pract 17(6):OP2000248, 2021. e-Pub 2021. PMID: 33596096.
39. Nitecki R, Melamed A, Gockley AA, Floyd J, Krause KJ, Coleman RL, Matulonis UA, Giordano SH, Lu KH, Rauh-Hain JA. Incidence of myelodysplastic syndrome and acute myeloid leukemia in patients receiving poly-ADP ribose polymerase inhibitors for the treatment of solid tumors: A meta-analysis of randomized trials. Gynecol Oncol 161(3):653-659, 2021. e-Pub 2021. PMID: 33736856.
40. Nitecki R, Clapp MA, Fu S, Lamiman K, Melamed A, Brady PC, Kaimal A, Del Carmen MG, Woodard TL, Meyer LA, Giordano SH, Ramirez PT, Rauh-Hain JA. Outcomes of the first pregnancy after fertility-sparing surgery for early-stage ovarian cancer. Obstet Gynecol 137(6):1109-1118, 2021. PMID: 33957660.
41. Lu H, Lei X, Zhao H, Elting L, Siricilla M, Ursani MA, Giordano SH, Suarez-Almazor M. Bone mineral density at the time of initiating aromatase inhibitor therapy is associated with decreased fractures in women with breast cancer. J Bone Miner Res 36(5):861-871, 2021. e-Pub 2021. PMID: 33484602.
42. Yao CMKL, Fu S, Tam S, Kiong KL, Guo T, Zhao H, Giordano SH, Sturgis EM, Lewis CM. Impact of provider type and number of providers on surveillance testing among survivors of head and neck cancers. Cancer 127(10):1699-1711, 2021. e-Pub 2021. PMID: 33471396.
43. Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, Blair SL, Burstein HJ, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, Hurvitz SA, Isakoff SJ, Jankowitz RC, Javid SH, Krishnamurthy J, Leitch M, Lyons J, Matro J, Mayer IA, Mortimer J, O'Regan RM, Patel SA, Pierce LJ, Rugo HS, Sitapati A, Smith KL, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Ward JH, Wisinski KB, Young JS, Burns JL, Kumar R. NCCN Guidelines® Insights: Breast Cancer, Version 4.2021. J Natl Compr Canc Netw 19(5):484-493, 2021. e-Pub 2021. PMID: 34030128.
44. Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, Blair SL, Burstein HJ, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, Hurvitz SA, Isakoff SJ, Jankowitz RC, Javid SH, Krishnamurthy J, Leitch M, Lyons J, Matro J, Mayer IA, Mortimer J, O'Regan RM, Patel SA, Pierce LJ, Rugo HS, Sitapati A, Smith KL, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Ward JH, Wisinski KB, Young JS, Burns JL, Kumar R. NCCN Guidelines® Insights: Breast Cancer, Version 4.2021. J Natl Compr Canc Netw 19(5):484-493, 2021. e-Pub 2021. PMID: 34794122.
45. Denduluri N, Somerfield MR, Chavez-MacGregor M, Comander AH, Dayao Z, Eisen A, Freedman RA, Gopalakrishnan R, Graff SL, Hassett MJ, King TA, Lyman GH, Maupin GR, Nunes R, Perkins CL, Telli ML, Trudeau ME, Wolff AC, Giordano SH. Selection of optimal adjuvant chemotherapy and targeted therapy for early breast cancer: ASCO guideline update. J Clin Oncol 39(6):JCO2002510, 2021. e-Pub 2020. PMID: 33079579.
46. Nitecki R, Fu S, Lefkowits C, Smith BD, Meyer LA, Melamed A, Giordano SH, Rauh-Hain JA. Employment disruption following the diagnosis of endometrial cancer. Gynecol Oncol 160(1):199-205, 2021. e-Pub 2020. PMID: 33183765.
47. Thompson MR, Niu J, Lei X, Nowakowska M, Wehner MR, Giordano SH, Nead KT. Association of endocrine therapy and dementia in women with breast cancer. Breast Cancer (Dove Med Press) 13:219-224, 2021. e-Pub 2021. PMID: 33854369.
48. Roy M, Teshome M, Damodaran S, Sahin AA, Khazai L, Arribas E, Candelaria RP, Scoggins ME, Lane DL, Giordano SH, Albarracin CT, Prieto VG, Nagarajan P. Male mammary paget disease: A Tale of 2 contrasting cases. Am J Dermatopathol 42(12):981-985, 2020. PMID: 33289978.
49. Sharma M, Duan Z, Zhao H, Giordano SH, Chavez-MacGregor M. Real-world patterns of everolimus use in patients with metastatic breast cancer. Oncologist 25(11):937-942, 2020. e-Pub 2020. PMID: 32476216.
50. Shen C, Thornton JD, Gu D, Dodge D, Zhou S, He W, Zhao H, Giordano SH. Prolonged opioid use after surgery for early-stage breast cancer. Oncologist 25(10):e1574-e1582, 2020. e-Pub 2020. PMID: 32390251.
51. Tamirisa N, Lin H, Shen Y, Shaitelman SF, Sri Karuturi M, Giordano SH, Babiera G, Bedrosian I. Association of chemotherapy with survival in elderly patients with multiple comorbidities and estrogen receptor-positive, node-positive breast cancer. JAMA Oncol 6(10):1548-1554, 2020. e-Pub 2020. PMID: 32672820.
52. Smith-Graziani D, Lei X, Giordano SH, Zhao H, Karuturi M, Chavez-MacGregor M. Delayed initiation of adjuvant chemotherapy in older women with breast cancer. Cancer Med 9(19):6961-6971, 2020. e-Pub 2020. PMID: 32767723.
53. Suarez-Almazor ME, Herrera R, Lei X, Chavez-MacGregor M, Zhao H, Giordano SH. Survival in older women with early stage breast cancer receiving low-dose bisphosphonates or denosumab. Cancer 126(17):3929-3938, 2020. e-Pub 2020. PMID: 32573777.
54. de Melo Gagliato D, Lei X, Giordano SH, Valero V, Barcenas CH, Hortobagyi GN, Chavez-MacGregor M. Impact of delayed neoadjuvant systemic chemotherapy on overall survival among breast cancer patients. Oncologist 25(9):749-757, 2020. e-Pub 2020. PMID: 32431013.
55. Hassett MJ, Somerfield MR, Giordano SH. Management of male breast cancer: ASCO guideline summary. JCO Oncol Pract 16(8):JOP1900792, 2020. e-Pub 2020. PMID: 32091951.
56. Dottino JA, He W, Sun CC, Zhao H, Fu S, Rauh-Hain JA, Suidan RS, Lu KH, Giordano SH, Meyer LA. National trends in bowel and upper abdominal procedures in ovarian cancer surgery. Int J Gynecol Cancer 30(8):1195-1202, 2020. e-Pub 2020. PMID: 32616627.
57. Elting LS, Liao KP, Giordano SH, Guadagnolo BA. Hospice enrollment among cancer patients in Texas covered by Medicare managed care and traditional fee-for-service plans: a statewide population-based study. Support Care Cancer 28(7):3351-3359, 2020. e-Pub 2019. PMID: 31760519.
58. Kantor O, Niu J, Zhao H, Giordano SH, Hunt KK, King TA, Mittendorf EA, Chavez-MacGregor M. Comparative analysis of proposed strategies for incorporating biologic factors into breast cancer staging. Ann Surg Oncol 27(7):2229-2237, 2020. e-Pub 2020. PMID: 31916091.
59. Hassett MJ, Somerfield MR, Baker ER, Cardoso F, Kansal KJ, Kwait DC, Plichta JK, Ricker C, Roshal A, Ruddy KJ, Safer JD, Van Poznak C, Yung RL, Giordano SH. Management of male breast cancer: ASCO guideline. J Clin Oncol 38(16):JCO1903120, 2020. e-Pub 2020. PMID: 32058842.
60. Corrigan KL, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Piotrowski M, Fuller CD, Stauder MC, Shaitelman SF, Perkins GH, Woodward WA, Giordano SH, Smith BD, Ludmir EB. Exclusion of men from randomized phase III breast cancer clinical trials. Oncologist 25(6):e990-e992, 2020. e-Pub 2020. PMID: 32272505.
61. Ost DE, Niu J, Zhao H, Grosu HB, Giordano SH. Quality gaps and comparative effectiveness in lung cancer staging and diagnosis. Chest 157(5):1322-1345, 2020. e-Pub 2019. PMID: 31610159.
62. Smith BD, Lei X, Diao K, Xu Y, Shen Y, Smith GL, Giordano SH, DeSnyder SM, Hunt KK, Teshome M, Jagsi R, Shaitelman SF, Peterson SK, Swanick CW. Effect of surgeon factors on long-term patient-reported outcomes after breast-conserving therapy in older breast cancer survivors. Ann Surg Oncol 27(4):1013-1022, 2020. e-Pub 2020. PMID: 31916092.
63. Sharma M, Johnson ML, Zhao H, Giordano SH, Holmes HM. Concordance between electronic health record data and medicare Part D claims data for oral anticancer drug use. JAMA Netw Open 3(4):e203821, 2020. e-Pub 2020. PMID: 32352527.
64. Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH, Blair SL, Burstein HJ, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Krishnamurthy J, Lyons J, Marcom PK, Matro J, Mayer IA, Moran MS, Mortimer J, O'Regan RM, Patel SA, Pierce LJ, Rugo HS, Sitapati A, Smith KL, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Ward JH, Young JS, Burns JL, Kumar R. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 18(4):452-478, 2020. PMID: 32259783.
65. Kehl KL, Keating NL, Giordano SH, Schrag D. Insurance networks and access to affordable cancer care. J Clin Oncol 38(4):JCO1901484, 2020. e-Pub 2019. PMID: 31804867.
66. Harrison R, Zhao H, Sun CC, Fu S, Armbruster SD, Westin SN, Rauh-Hain JA, Lu KH, Giordano SH, Meyer LA. Body mass index and attitudes towards health behaviors among women with endometrial cancer before and after treatment. Int J Gynecol Cancer 30(2):187-192, 2020. e-Pub 2019. PMID: 31843871.
67. Nelson DB, Niu J, Mitchell KG, Antonoff MB, Giordano SH, Hofstetter WL, Vaporciyan AA, Sepesi B, Mehran RJ, Rice DC. Perioperative outcomes among chronic opioid users who receive lobectomy for non-small cell lung cancer. J Thorac Cardiovasc Surg 159(2):691-702.e5, 2020. e-Pub 2019. PMID: 33003262.
68. Nelson DB, Niu J, Mitchell KG, Sepesi B, Hofstetter WL, Antonoff MB, Giordano SH, Mehran RJ, Rice DC. Persistent opioid use among the elderly after lung resection: a SEER-Medicare study. Ann Thorac Surg 109(1):194-202, 2020. e-Pub 2019. PMID: 31445908.
69. Karuturi MS, Lei X, Shen Y, Giordano SH, Swanick CW, Smith BD. Long-term decision regret surrounding systemic therapy in older breast cancer survivors: A population-based survey study. J Geriatr Oncol 10(6):973-979, 2019. e-Pub 2019. PMID: 30940493.
70. Harrison RF, He W, Fu S, Zhao H, Sun CC, Suidan RS, Woodard TL, Rauh-Hain JA, Westin SN, Giordano SH, Meyer LA. National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia. Am J Obstet Gynecol 221(5):474.e1-474.e11, 2019. e-Pub 2019. PMID: 31128110.
71. Fu S, Wang M, Zhao H, Li R, Lairson DR, Giordano SH, Zhao B, Du XL. Comparative effectiveness of chemotherapy, rituximab, and bendamustine in medicare beneficiaries with mantle-cell lymphoma. Clin Lymphoma Myeloma Leuk 19(11):e616-e623, 2019. e-Pub 2019. PMID: 31563564.
72. Nelson DB, Cata JP, Niu J, Mitchell KG, Vaporciyan AA, Antonoff MB, Hofstetter WL, Giordano SH, Sepesi B, Mehran RJ, Rice DC. Persistent opioid use is associated with worse survival after lobectomy for stage i non-small cell lung cancer. Pain 160(10):2365-2373, 2019. e-Pub 2019. PMID: 31149979.
73. Smith GL, Lopez-Olivo MA, Advani PG, Ning MS, Geng Y, Giordano SH, Volk RJ. Financial burdens of cancer treatment: a systematic review of risk factors and outcomes. J Natl Compr Canc Netw 17(10):1184-1192, 2019. PMID: 31590147.
74. Karuturi MS, Holmes HM, Lei X, Johnson M, Barcenas CH, Cantor SB, Gallick GE, Bast RC, Giordano SH. Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancer. J Geriatr Oncol 10(5):705-708, 2019. e-Pub 2019. PMID: 30795923.
75. Wang JR, Nurgalieva Z, Fu S, Tam S, Zhao H, Giordano SH, Hutcheson KA, Lewis CM. Utilization of rehabilitation services in patients with head and neck cancer in the United States: A SEER-Medicare analysis. Head Neck 41(9):3299-3308, 2019. e-Pub 2019. PMID: 31240808.
76. Suidan RS, He W, Sun CC, Zhao H, Rauh-Hain JA, Fleming ND, Lu KH, Giordano SH, Meyer LA. Total and out-of-pocket costs of different primary management strategies in ovarian cancer. Am J Obstet Gynecol 221(2):136.e1-136.e9, 2019. e-Pub 2019. PMID: 30965052.
77. Fang P, Jagsi R, He W, Lei X, Campbell EG, Giordano SH, Smith GL. Rising and falling trends in the use of chemotherapy and targeted therapy near the end of life in older patients with cancer. J Clin Oncol 37(20):JCO1802067, 2019. e-Pub 2019. PMID: 31141431.
78. Hoover DS, Pappadis MR, Housten AJ, Krishnan S, Weller SC, Giordano SH, Bevers TB, Goodwin JS, Volk RJ. Preferences for communicating about breast cancer screening among racially/ethnically diverse older women. Health Commun 34(7):1-5, 2019. e-Pub 2018. PMID: 29373069.
79. Advani PG, Lei X, Swanick CW, Xu Y, Shen Y, Goodwin NA, Smith GL, Giordano SH, Hunt KK, Jagsi R, Smith BD. Local-therapy decisional regret in older women with breast cancer: A population-based study. Int J Radiat Oncol Biol Phys 104(2):383-391, 2019. e-Pub 2019. PMID: 30716524.
80. Lim B, Murthy RK, Lee J, Jackson SA, Iwase T, Davis DW, Willey JS, Wu J, Shen Y, Tripathy D, Alvarez R, Ibrahim NK, Brewster AM, Barcenas CH, Brown PH, Giordano SH, Moulder SL, Booser DJ, Moscow JA, Piekarz R, Valero V, Ueno NT. A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment. Br J Cancer 120(12):1105-1112, 2019. e-Pub 2019. PMID: 31097774.
81. Fried DA, Sadeghi-Nejad H, Gu D, Zhou S, He W, Giordano SH, Pentakota SR, Demissie K, Helmer D, Shen C. Impact of serious mental illness on the treatment and mortality of older patients with locoregional high-grade (nonmetastatic) prostate cancer: retrospective cohort analysis of 49 985 SEER-Medicare patients diagnosed between 2006 and 2013. Cancer Med 8(5):2612-2622, 2019. e-Pub 2019. PMID: 30945473.
82. Sharma M, Holmes HM, Mehta HB, Chen H, Aparasu RR, Shih YT, Giordano SH, Johnson ML. The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: prevalence, predictors and impact on survival and discontinuation of therapy in older adults with cancer. Cancer 125(7):1155-1162, 2019. e-Pub 2019. PMID: 30605231.
83. Sharma M, Vadhariya A, Chikermane S, Gopinathan S, Chavez-MacGregor M, Giordano SH, Johnson ML, Holmes HM. Clinical outcomes associated with drug-drug interactions of oral chemotherapeutic agents: a comprehensive evidence-based literature review. Drugs Aging 36(4):341-354, 2019. e-Pub 2019. PMID: 30714077.
84. Logan JK, Jiang J, Shih YT, Lei X, Xu Y, Hoffman KE, Giordano SH, Smith BD. Trends in radiation for bone metastasis during a period of multiple national quality improvement initiatives. J Oncol Pract 15(4):e356-e368, 2019. e-Pub 2019. PMID: 30849005.
85. Taylor JS, Zhang N, Rajan SS, Chavez-MacGregor M, Zhao H, Niu J, Meyer LA, Ramondetta LM, Bodurka DC, Lairson DR, Giordano SH. How we use hospice: hospice enrollment patterns and costs in elderly ovarian cancer patients. Gynecol Oncol 152(3):452-458, 2019. PMID: 30876488.
86. Suidan RS, He W, Sun CC, Zhao H, Smith GL, Klopp AH, Fleming ND, Lu KH, Giordano SH, Meyer LA. National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer. Gynecol Oncol 152(3):439-444, 2019. PMID: 30876486.
87. Rauh-Hain JA, Hidrue MK, Gaccione P, Melamed A, Meyer LA, Keating NL, Giordano SH, Rice LW, Birrer MJ, Del Carmen MG. Variation in resource utilization associated with the surgical management of ovarian cancer. Gynecol Oncol 152(3):587-593, 2019. e-Pub 2018. PMID: 30579568.
88. Hwang JP, Huang D, Vierling JM, Suarez-Almazor ME, Shih YT, Chavez-MacGregor M, Duan Z, Giordano SH, Hershman DL, Fisch MJ, Cantor SB. Cost-effectiveness analysis of hepatitis B virus screening and management in patients with hematologic or solid malignancies anticipating immunosuppressive cancer therapy. JCO Clin Cancer Inform 3:1-12, 2019. PMID: 30892921.
89. Cunningham SA, Yu R, Shih T, Giordano S, McNeill LH, Rechis R, Peterson SK, Cinciripini P, Foxhall L, Hawk E, Shete S. Perceived cancer-related risk and beliefs in Texas: findings from a 2018 population-level survey. Cancer Epidemiol Biomarkers Prev 28(3):486-494, 2019. e-Pub 2019. PMID: 30700446.
90. Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KA, Giordano SH, Hudis CA, Solky AJ, Stearns V, Winer EP, Griggs JJ. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol 37(5):JCO1801160, 2019. e-Pub 2018. PMID: 30452337.
91. Hutcheson KA, Nurgalieva Z, Zhao H, Gunn GB, Giordano SH, Bhayani MK, Lewin JS, Lewis CM. Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis. Head Neck 41(2):479-487, 2019. e-Pub 2018. PMID: 30536748.
92. Moreno AC, Zhang N, Verma V, Giordano SH, Lin SH. Treatment disparities affect outcomes for patients with stage I esophageal cancer: a national cancer data base analysis. J Gastrointest Oncol 10(1):74-84, 2019. PMID: 30788162.
93. Goetz MP, Gradishar WJ, Anderson BO, Abraham J, Aft R, Allison KH, Blair SL, Burstein HJ, Dang C, Elias AD, Farrar WB, Giordano SH, Goldstein LJ, Isakoff SJ, Lyons J, Marcom PK, Mayer IA, Moran MS, Mortimer J, O'Regan RM, Patel SA, Pierce LJ, Reed EC, Rugo HS, Sitapati A, Smith KL, Smith ML, Soliman H, Telli ML, Ward JH, Young JS, Shead DA, Kumar R. NCCN Guidelines Insights: Breast Cancer, Version 3.2018. J Natl Compr Canc Netw 17(2):118-126, 2019. PMID: 30787125.
94. Kehl KL, Niu J, Chavez-MacGregor M, Giordano SH. Hospitalization by cytotoxic chemotherapy regimen among older women with stage IV breast cancer. Cancer 124(24):4685-4691, 2018. e-Pub 2018. PMID: 30264853.
95. Murthy RK, Raghavendra AS, Hess KR, Fujii T, Lim B, Barcenas CH, Zhang H, Chavez-Mac-Gregor M, Mittendorf EA, Litton JK, Giordano SH, Thompson AM, Valero V, Moulder SL, Tripathy D, Ueno NT. Neoadjuvant pertuzumab-containing regimens improve pathologic complete response rates in stage II to III hER-2/neu-positive breast cancer: A retrospective, single institution experience. Clin Breast Cancer 18(6):e1283-e1288, 2018. e-Pub 2018. PMID: 30077429.
96. Yam C, Murthy RK, Rauch GM, Murray JL, Walters RS, Valero V, Brewster AM, Bast RC, Booser DJ, Giordano SH, Esteva FJ, Yang W, Hortobagyi GN, Moulder SL, Arun B. A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-β. Invest New Drugs 36(6):1103-1109, 2018. e-Pub 2018. PMID: 30311036.
97. Taylor JS, He W, Harrison R, Zhao H, Sun CC, Lu KH, Giordano SH, Meyer LA. Disparities in treatment and survival among elderly ovarian cancer patients. Gynecol Oncol 151(2):269-274, 2018. e-Pub 2018. PMID: 30253875.
98. Meyer LA, He W, Sun CC, Zhao H, Wright AA, Suidan RS, Dottino J, Alejandro Rauh-Hain J, Lu KH, Giordano SH. Neoadjuvant chemotherapy in elderly women with ovarian cancer: rates of use and effectiveness. Gynecol Oncol 150(3):451-459, 2018. e-Pub 2018. PMID: 29961559.
99. Ramakrishna N, Temin S, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Giordano SH, Kirshner JJ, Krop IE, Levinson J, Modi S, Patt DA, Perlmutter J, Winer EP, Lin NU. Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: ASCO clinical practice guideline update. J Clin Oncol 36(27):JCO2018792713, 2018. e-Pub 2018. PMID: 29939840.
100. Giordano SH, Temin S, Chandarlapaty S, Crews JR, Esteva FJ, Kirshner JJ, Krop IE, Levinson J, Lin NU, Modi S, Patt DA, Perlmutter J, Ramakrishna N, Winer EP, Davidson NE. Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: ASCO clinical practice guideline update. J Clin Oncol 36(26):JCO2018792697, 2018. e-Pub 2018. PMID: 29939838.
101. Guo F, Kuo YF, Shih YCT, Giordano SH, Berenson AB. Trends in breast cancer mortality by stage at diagnosis among young women in the United States. Cancer 124(17):3500-3509, 2018. e-Pub 2018. PMID: 30189117.
102. Chance WW, Ortiz-Ortiz KJ, Liao KP, Zavala Zegarra DE, Stauder MC, Giordano SH, Tortolero-Luna G, Guadagnolo BA. Underuse of radiation therapy after breast conservation surgery in Puerto Rico: a Puerto Rico central cancer registry-health insurance linkage database study. J Glob Oncol(4):1-9, 2018. e-Pub 2017. PMID: 30241162.
103. Denduluri N, Chavez-MacGregor M, Telli ML, Eisen A, Graff SL, Hassett MJ, Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Somerfield MR, Trudeau ME, Wolff AC, Giordano SH. Selection of optimal adjuvant chemotherapy and targeted therapy for early breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol 36(23):JCO2018788604, 2018. e-Pub 2018. PMID: 29787356.
104. Denduluri N, Somerfield MR, Giordano SH. Selection of optimal adjuvant chemotherapy and targeted therapy for early breast cancer: ASCO clinical practice guideline focused update summary. J Oncol Pract 14(8):JOP1800207, 2018. e-Pub 2018. PMID: 29924666.
105. Giordano SH, Temin S, Davidson NE. Systemic therapy for patients with advanced human epidermal growth factor receptor 2-Positive breast cancer: ASCO Clinical Practice Guideline Update Summary. J Oncol Pract 14(8):JOP1800290, 2018. e-Pub 2018. PMID: 29989839.
106. Henry ML, Niu J, Zhang N, Giordano SH, Chavez-MacGregor M. Cardiotoxicity and cardiac monitoring among chemotherapy-treated breast cancer patients. JACC Cardiovasc Imaging 11(8):1084-1093, 2018. PMID: 30092967.
107. Deshmukh AA, Zhao H, Das P, Chiao EY, You YN, Franzini L, Lairson DR, Swartz MD, Giordano SH, Cantor SB. Clinical and economic evaluation of treatment strategies for T1N0 anal canal cancer. Am J Clin Oncol 41(7):626-631, 2018. e-Pub 2016. PMID: 27755059.
108. Hirth JM, Hatch SS, Lin YL, Giordano SH, Silva HC, Kuo YF. Development and validation of algorithms to differentiate ductal carcinoma in situ from invasive breast cancer within administrative claims data. Cancer 124(13):2815-2823, 2018. e-Pub 2018. PMID: 29669162.
109. Karuturi MS, Holmes HM, Lei X, Johnson M, Barcenas CH, Cantor SB, Gallick GE, Bast RC, Giordano SH. Potentially inappropriate medication use in older patients with breast and colorectal cancer. Cancer 124(14):3000-3007, 2018. e-Pub 2018. PMID: 29689595.
110. Suidan RS, Sun CC, Cantor SB, Mariani A, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer LA. Three lymphadenectomy strategies in low-risk endometrial carcinoma: a cost-effectiveness analysis. Obstet Gynecol 132(1):52-58, 2018. e-Pub 2018. PMID: 29889752.
111. Kim J, Rajan SS, Du XL, Franzini L, Giordano SH, Morgan RO. Association between financial burden and adjuvant hormonal therapy adherence and persistent use for privately insured women aged 18-64 years in BCBS of Texas. Breast Cancer Res Treat 169(3):573-586, 2018. e-Pub 2018. PMID: 29423900.
112. van la Parra RFD, Liao K, Smith BD, Yang WT, Leung JWT, Giordano SH, Kuerer HM. Incidence and outcome of breast biopsy procedures during follow-up after treatment for breast cancer. JAMA Surg 153(6):559-568, 2018. e-Pub 2018. PMID: 29387884.
113. Housten AJ, Pappadis MR, Krishnan S, Weller SC, Giordano SH, Bevers TB, Volk RJ, Hoover DS. Resistance to discontinuing breast cancer screening in older women: A qualitative study. Psychooncology 27(6):1635-1641, 2018. e-Pub 2018. PMID: 29575590.
114. Pappadis MR, Volk RJ, Krishnan S, Weller SC, Jaramillo E, Hoover DS, Giordano SH, Tan A, Sheffield KM, Housten AJ, Goodwin JS. Perceptions of overdetection of breast cancer among women 70 years of age and older in the USA: a mixed-methods analysis. BMJ Open 8(6):e022138, 2018. e-Pub 2018. PMID: 29903800.
115. Giordano SH. Breast Cancer in Men. N Engl J Med 378(24):2311-2320, 2018. PMID: 29897847.
116. Nelson DB, Rice DC, Niu J, Atay SM, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao AS, Gomez DR, Giordano SH, Mehran RJ, Sepesi B. Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma. Eur J Cardiothorac Surg 53(5):960-966, 2018. e-Pub 2017. PMID: 29211849.
117. Hwang JP, Ahmed S, Ariza-Heredia EJ, Duan Z, Zhao H, Schmeler KM, Ramondetta L, Parker SL, Suarez-Almazor ME, Ferrajoli A, Shih YT, Giordano SH, Chiao EY. Low rate of cervical cancer screening among women with hematologic malignancies after stem cell transplant. Biol Blood Marrow Transplant 24(5):1094-1098, 2018. e-Pub 2018. PMID: 29378304.
118. Giordano SH, Elias AD, Gradishar WJ. NCCN Guidelines Updates: Breast Cancer. J Natl Compr Canc Netw 16(5S):605-610, 2018. PMID: 29784737.
119. Rosenstock AS, Niu J, Giordano SH, Zhao H, Wolff AC, Chavez-MacGregor M. Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients. Cancer 124(5):899-906, 2018. e-Pub 2017. PMID: 29236294.
120. Swanick CW, Lei X, Xu Y, Shen Y, Goodwin NA, Smith GL, Giordano SH, Hunt KK, Jagsi R, Shaitelman SF, Peterson SK, Smith BD. Long-term patient-reported outcomes in older breast cancer survivors: A population-based survey study. Int J Radiat Oncol Biol Phys 100(4):882-890, 2018. e-Pub 2017. PMID: 29485067.
121. Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Lyons J, Marcom PK, Mayer IA, McCormick B, Moran MS, O'Regan RM, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Sitapati A, Smith KL, Smith ML, Soliman H, Somlo G, Telli ML, Ward JH, Kumar R, Shead DA. Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16(3):310-320, 2018. PMID: 29523670.
122. Deshmukh AA, Zhao H, Franzini L, Lairson DR, Chiao EY, Das P, Swartz MD, Giordano SH, Cantor SB. Total lifetime and cancer-related costs for elderly patients diagnosed with anal cancer in the United States. Am J Clin Oncol 41(2):121-127, 2018. e-Pub 2015. PMID: 26523440.
123. Ost DE, Niu J, Zhao H, Grosu HB, Giordano SH. Quality gaps and comparative effectiveness of management strategies for recurrent malignant pleural effusions. Chest 153(2):438-452, 2018. e-Pub 2017. PMID: 28864054.
124. Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P, Linderholm B, Hedenfalk I, Schröder C, Martens J, Bayani J, van Asperen C, Murray M, Hudis C, Middleton L, Vermeij J, Punie K, Fraser J, Nowaczyk M, Rubio IT, Aebi S, Kelly C, Ruddy KJ, Winer E, Nilsson C, Dal Lago L, Korde L, Benstead K, Bogler O, Goulioti T, Peric A, Litière S, Aalders KC, Poncet C, Tryfonidis K, Giordano SH. Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Ann Oncol 29(2):405-417, 2018. e-Pub 2017. PMID: 29092024.
125. Weiss A, Chavez-MacGregor M, Lichtensztajn DY, Yi M, Tadros A, Hortobagyi GN, Giordano SH, Hunt KK, Mittendorf EA. Validation study of the American Joint Committee on Cancer eighth edition prognostic stage compared with the anatomic stage in breast cancer. JAMA Oncol 4(2):203-209, 2018. e-Pub 2017. PMID: 29222540.
126. Zhao H, Zhang N, Ho V, Ding M, He W, Niu J, Yang M, Du XL, Zorzi D, Chavez-MacGregor M, Giordano SH. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011. Cancer 124(4):679-687, 2018. e-Pub 2017. PMID: 29140558.
127. Moreno AC, Zhang N, Giordano SH, Liao Z, Gomez D, Chang JY, Lin SH. Trends and outcomes of proton radiation therapy use for non-small cell lung cancer. Int J Part Ther 5(2):18-27, 2018. e-Pub 2018. PMID: 31773031.
128. Chavez-MacGregor M, Mittendorf EA, Clarke CA, Lichtensztajn DY, Hunt KK, Giordano SH. Incorporating tumor characteristics to the American Joint Committee on Cancer Breast Cancer Staging System. Oncologist 22(11):1292-1300, 2017. e-Pub 2017. PMID: 28592619.
129. Mittendorf EA, Chavez-MacGregor M, Vila J, Yi M, Lichtensztajn DY, Clarke CA, Giordano SH, Hunt KK. Bioscore: A staging system for breast cancer patients that reflects the prognostic significance of underlying tumor biology. Ann Surg Oncol 24(12):3502-3509, 2017. e-Pub 2017. PMID: 28726077.
130. Shih YT, Xu Y, Chavez-MacGregor M, Guadagnolo BA, Smith BD, Giordano SH. Association between quality of care for breast cancer and health insurance exchange coverage: An analysis of use of radiation therapy after breast-conserving surgery. JAMA Oncol 3(10):1425-1426, 2017. e-Pub 2017. PMID: 28570719.
131. Nelson DB, Rice DC, Niu J, Atay S, Vaporciyan AA, Antonoff M, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao A, Gomez D, Giordano SH, Mehran R, Sepesi B. Long-term survival outcomes of cancer directed surgery for malignant pleural mesothelioma-propensity score matching analysis. J Clin Oncol 35(29):JCO2017738401, 2017. e-Pub 2017. PMID: 28817374.
132. Vermeulen MA, Slaets L, Cardoso F, Giordano SH, Tryfonidis K, van Diest PJ, Dijkstra NH, Schröder CP, van Asperen CJ, Linderholm B, Benstead K, Foekens R, Martens JWM, Bartlett JMS, van Deurzen CHM. Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Eur J Cancer 82:219-227, 2017. e-Pub 2017. PMID: 28292559.
133. Suidan RS, He W, Sun CC, Zhao H, Ramondetta LM, Badgwell BD, Bodurka DC, Lu KH, Giordano SH, Meyer LA. Treatment patterns, outcomes, and costs for bowel obstruction in ovarian cancer. Int J Gynecol Cancer 27(7):1350-1359, 2017. e-Pub 2017. PMID: 28574929.
134. Williams SB, Duan Z, Chamie K, Hoffman KE, Smith BD, Hu JC, Shah JB, Davis JW, Giordano SH. Risk of hospitalisation following primary treatment for prostate cancer. BJU Int 120(1):48-55, 2017. e-Pub 2016. PMID: 27561186.
135. Shen C, Kehl KL, Zhao B, Simon GR, Zhou S, Giordano SH. Utilization patterns and trends in epidermal growth factor receptor (EGFR) mutation testing among patients with newly diagnosed metastatic lung cancer. Clin Lung Cancer 18(4):e233-e241, 2017. e-Pub 2016. PMID: 28024927.
136. Fang P, He W, Gomez DR, Hoffman KE, Smith BD, Giordano SH, Jagsi R, Smith GL. Influence of age on guideline-concordant cancer care for elderly patients in the United States. Int J Radiat Oncol Biol Phys 98(4):748-757, 2017. e-Pub 2017. PMID: 28366580.
137. Barcenas CH, Raghavendra A, Sinha AK, Syed MP, Hsu L, Patangan MG, Chavez-MacGregor M, Shen Y, Hortobagyi GH, Valero V, Giordano SH, Ueno NT, Tripathy D. Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay. Cancer 123(13):2422-2431, 2017. e-Pub 2017. PMID: 28199747.
138. Williams SB, Huo J, Kosarek CD, Chamie K, Rogers SO, Williams MA, Giordano SH, Kim SP, Kamat AM. Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer. Cancer Causes Control 28(7):755-766, 2017. e-Pub 2017. PMID: 28477210.
139. Pasalic D, Jiang J, Jagsi R, Giordano SH, Smith BD. Association of insurance status with the use of immediate breast reconstruction in women with breast cancer. Plast Reconstr Surg Glob Open 5(7):e1360, 2017. e-Pub 2017. PMID: 28831333.
140. Huo J, Chu Y, Chamie K, Smaldone MC, Boorjian SA, Baillargeon JG, Kuo YF, Kerr P, O'Malley P, Orihuela E, Tyler DS, Freedland SJ, Giordano SH, Vikram R, Kamat AM, Williams SB. Increased utilization of positron emission tomography/computed tomography (PET/CT) imaging and its economic impact for patients diagnosed with bladder cancer. Clin Genitourin Cancer. e-Pub 2017. PMID: 28826932.
141. Taylor JS, Rajan SS, Zhang N, Meyer LA, Ramondetta LM, Bodurka DC, Lairson DR, Giordano SH. End-of-life racial and ethnic disparities among patients with ovarian cancer. J Clin Oncol 35(16):JCO2016702894, 2017. e-Pub 2017. PMID: 28388292.
142. Zhao H, Hei N, Wu Y, Chan W, Lei X, Cameron C, Chang S, Chavez-MacGregor M, Giordano SH. Initiation of and adherence to tamoxifen and aromatase inhibitor therapy among elderly women with ductal carcinoma in situ. Cancer 123(6):940-947, 2017. e-Pub 2016. PMID: 27780311.
143. Williams SB, Huo J, Chamie K, Smaldone MC, Kosarek CD, Fang JE, Ynalvez LA, Kim SP, Hoffman KE, Giordano SH, Chapin BF. Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data. Cancer 123(9):1617-1624, 2017. e-Pub 2017. PMID: 28099688.
144. Doebar SC, Slaets L, Cardoso F, Giordano SH, Bartlett JM, Tryfonidis K, Dijkstra NH, Schröder CP, van Asperen CJ, Linderholm B, Benstead K, Dinjens WN, van Marion R, van Diest PJ, Martens JW, van Deurzen CH. Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Mod Pathol 30(4):509-518, 2017. e-Pub 2017. PMID: 28084333.
145. Suidan RS, He W, Sun CC, Zhao H, Fleming ND, Ramirez PT, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer LA. Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia. Gynecol Oncol 145(1):55-60, 2017. e-Pub 2017. PMID: 28131529.
146. Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Lyons J, Marcom PK, Mayer IA, McCormick B, Moran MS, O'Regan RM, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Sitapati A, Smith KL, Smith ML, Soliman H, Somlo G, Telli M, Ward JH, Shead DA, Kumar R. NCCN Guidelines Insights: Breast Cancer Version 1.2017. J Natl Compr Canc Netw 15(4):433-451, 2017. PMID: 28404755.
147. Williams SB, Huo J, Chamie K, Hu JC, Giordano SH, Hoffman KE, Dinney CPN, Kamat AM, Shih YT. Underutilization of radical cystectomy among patients diagnosed with clinical stage T2 muscle-invasive bladder cancer. Eur Urol Focus 3(2-3):258-264, 2017. e-Pub 2016. PMID: 28753760.
148. Kehl KL, Liao KP, Krause TM, Giordano SH. Access to accredited cancer hospitals within federal exchange plans under the Affordable Care Act. J Clin Oncol 35(6):JCO2016699835, 2017. e-Pub 2017. PMID: 28068172.
149. Fujii T, Kogawa T, Wu J, Sahin AA, Liu DD, Chavez-MacGregor M, Giordano SH, Raghavendra A, Murthy RK, Tripathy D, Shen Y, Yamal JM, Ueno NT. Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy. Br J Cancer 116(4):509-514, 2017. e-Pub 2017. PMID: 28081544.
150. Beadle BM, Liao KP, Giordano SH, Garden AS, Hutcheson KA, Lai SY, Guadagnolo BA. Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis. Cancer 123(2):283-293, 2017. e-Pub 2016. PMID: 27662641.
151. Smith BD, Jiang J, Shih YC, Giordano SH, Huo J, Jagsi R, Momoh AO, Caudle AS, Hunt KK, Shaitelman SF, Buchholz TA, Shirvani SM. Cost and Complications of Local Therapies for Early-Stage Breast Cancer. J Natl Cancer Inst 109(1), 2017. e-Pub 2016. PMID: 27678203.
152. Sinha AK, Patel JR, Shen Y, Ueno NT, Giordano SH, Tripathy D, Lopez DS, Barcenas CH. Location of receipt of initial treatment and outcomes in long-term breast cancer survivors. PLoS One 12(1):e0170081, 2017. e-Pub 2017. PMID: 28085940.
153. Kuerer HM, Smith BD, Chavez-MacGregor M, Albarracin C, Barcenas CH, Santiago L, Edgerton ME, Rauch GM, Giordano SH, Sahin A, Krishnamurthy S, Woodward W, Tripathy D, Yang WT, Hunt KK. DCIS margins and breast conservation: MD Anderson Cancer Center multidisciplinary practice guidelines and outcomes. J Cancer 8(14):2653-2662, 2017. e-Pub 2017. PMID: 28928852.
154. Huo J, Smith BD, Giordano SH, Reece GP, Tina Shih YC. A comparison of patient-centered economic and clinical outcomes of post-mastectomy breast reconstruction between obese and non-obese patients. Breast 30:118-124, 2016. e-Pub 2016. PMID: 27697676.
155. Giordano SH, Niu J, Chavez-MacGregor M, Zhao H, Zorzi D, Shih YT, Smith BD, Shen C. Estimating regimen-specific costs of chemotherapy for breast cancer: Observational cohort study. Cancer 122(22):3447-3455, 2016. e-Pub 2016. PMID: 27723214.
156. Shen C, Meric-Bernstam F, Su X, Mendelsohn J, Giordano S. Prevalence of actionable mutations and copy number alterations and the price of a genomic testing panel. Oncotarget 7(44):71686-71695, 2016. PMID: 27634896.
157. Fayanju OM, Mayo TL, Spinks TE, Lee S, Barcenas CH, Smith BD, Giordano SH, Hwang RF, Ehlers RA, Selber JC, Walters R, Tripathy D, Hunt KK, Buchholz TA, Feeley TW, Kuerer HM. Value-based breast cancer care: A multidisciplinary approach for defining patient-centered outcomes. Ann Surg Oncol 23(8):2385-90, 2016. e-Pub 2016. PMID: 26979306.
158. Kehl KL, Shen C, Litton JK, Arun B, Giordano SH. Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancer. Breast Cancer Res Treat 159(1):201, 2016. e-Pub 2016. PMID: 27464794.
159. Steele JR, Jones AK, Clarke RK, Giordano SH, Shoemaker S. Oncology patient perceptions of the use of ionizing radiation in diagnostic imaging. J Am Coll Radiol 13(7):768-774.e2, 2016. e-Pub 2016. PMID: 27184856.
160. Elting LS, Xu Y, Chavez-MacGregor M, Giordano SH. Granulocyte growth factor use in elderly patients with non-Hodgkin's lymphoma in the United States: adherence to guidelines and comparative effectiveness. Support Care Cancer 24(6):2695-706, 2016. e-Pub 2016. PMID: 26797253.
161. Shirvani SM, Jiang J, Likhacheva A, Hoffman KE, Shaitelman SF, Caudle A, Buchholz TA, Giordano SH, Smith BD. Trends in local therapy utilization and cost for early-stage breast cancer in older women: Implications for payment and policy reform. Int J Radiat Oncol Biol Phys 95(2):605-16, 2016. e-Pub 2016. PMID: 27034179.
162. Rosenstock AS, Lei X, Tripathy D, Hortobagyi GN, Giordano SH, Chavez-MacGregor M. Short-term mortality in older patients treated with adjuvant chemotherapy for early-stage breast cancer. Breast Cancer Res Treat 157(2):339-50, 2016. e-Pub 2016. PMID: 27146586.
163. Huo J, Smith BD, Giordano SH, Reece GP, Shih YC. Post-mastectomy breast reconstruction and its subsequent complications: a comparison between obese and non-obese women with breast cancer. Breast Cancer Res Treat 157(2):373-83, 2016. e-Pub 2016. PMID: 27178333.
164. Sanford RA, Lei X, Barcenas CH, Mittendorf EA, Caudle AS, Valero V, Tripathy D, Giordano SH, Chavez-MacGregor M. Impact of time from completion of neoadjuvant chemotherapy to surgery on survival outcomes in breast cancer patients. Ann Surg Oncol 23(5):1515-21, 2016. e-Pub 2015. PMID: 26678405.
165. Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Solky AJ, Stearns V, Winer EP, Griggs JJ. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression. J Clin Oncol 34(14):1689-701, 2016. e-Pub 2016. PMID: 26884586.
166. Kehl KL, Giordano SH. BRCA1 and BRCA2 testing among young breast cancer survivors. JAMA Oncol 2(5):688-9, 2016. PMID: 27244682.
167. Lin SH, Zhang N, Godby J, Wang J, Marsh GD, Liao Z, Komaki R, Ho L, Hofstetter WL, Swisher SG, Mehran RJ, Buchholz TA, Elting LS, Giordano SH. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. Cancer 122(6):917-28, 2016. e-Pub 2015. PMID: 26716915.
168. Chavez-MacGregor M, Clarke CA, Lichtensztajn DY, Giordano SH. Delayed initiation of adjuvant chemotherapy among patients with breast cancer. JAMA Oncol 2(3):1-8, 2016. e-Pub 2015. PMID: 26659132.
169. Lin CC, Bruinooge SS, Kirkwood MK, Hershman DL, Jemal A, Guadagnolo BA, Yu JB, Hopkins S, Goldstein M, Bajorin D, Giordano SH, Kosty M, Arnone A, Hanley A, Stevens S, Olsen C. Association between geographic access to cancer care and receipt of radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 94(4):719-28, 2016. e-Pub 2015. PMID: 26972644.
170. Huo J, Giordano SH, Smith BD, Shaitelman SF, Smith GL. Contemporary toxicity profile of breast brachytherapy versus external beam radiation after lumpectomy for breast cancer. Int J Radiat Oncol Biol Phys 94(4):709-18, 2016. e-Pub 2015. PMID: 26972643.
171. Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz M, Goldstein LJ, Hudis CA, Isakoff SJ, Marcom PK, Mayer IA, McCormick B, Moran M, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Smith KL, Smith ML, Soliman H, Somlo G, Telli M, Ward JH, Shead DA, Kumar R. Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 14(3):324-54, 2016. PMID: 26957618.
172. Jagsi R, Jiang J, Momoh AO, Alderman A, Giordano SH, Buchholz TA, Pierce LJ, Kronowitz SJ, Smith BD. Complications after mastectomy and immediate breast reconstruction for breast cancer: A claims-based analysis. Ann Surg 263(2):219-27, 2016. e-Pub 2015. PMID: 25876011.
173. Kehl KL, Shen C, Litton JK, Arun B, Giordano SH. Rates of BRCA1/2 mutation testing among young survivors of breast cancer. Breast Cancer Res Treat 155(1):165-73, 2016. e-Pub 2015. PMID: 26706041.
174. Ho V, Ku-Goto MH, Zhao H, Hoffman KE, Smith BD, Giordano SH. Regional differences in recommended cancer treatment for the elderly. BMC Health Serv Res 16(1):262, 2016. e-Pub 2016. PMID: 27417075.
175. Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz M, Goldstein LJ, Hudis CA, Isakoff SJ, Marcom PK, Mayer IA, McCormick B, Moran M, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Smith KL, Smith ML, Soliman H, Somlo G, Telli M, Ward JH, Shead DA, Kumar R. Breast Cancer, Version 1.2016. J Natl Compr Canc Netw 13(12):1475-85, 2015. PMID: 26656517.
176. He W, Zhao H, Chan W, Lopez D, Shroff RT, Giordano SH. Underuse of surgical resection among elderly patients with early-stage pancreatic cancer. Surgery 158(5):1226-34, 2015. e-Pub 2015. PMID: 26138347.
177. Lin CC, Bruinooge SS, Kirkwood MK, Olsen C, Jemal A, Bajorin D, Giordano SH, Goldstein M, Guadagnolo BA, Kosty M, Hopkins S, Yu JB, Arnone A, Hanley A, Stevens S, Hershman DL. Association between geographic access to cancer care, insurance, and receipt of chemotherapy: geographic distribution of oncologists and travel distance. J Clin Oncol 33(28):3177-85, 2015. e-Pub 2015. PMID: 26304878.
178. Ning J, Peng S, Ueno N, Xu Y, Shih Y, Karuturi M, Giordano S, Shen Y. Has racial difference in cause-specific death improved in older patients with late-stage breast cancer?. Ann Oncol 26(10):2161-8, 2015. e-Pub 2015. PMID: 26223248.
179. Smith GL, Huo J, Giordano SH, Hunt KK, Buchholz TA, Smith BD. Utilization and outcomes of breast brachytherapy in younger women. Int J Radiat Oncol Biol Phys 93(1):91-101, 2015. e-Pub 2015. PMID: 26279027.
180. Guadagnolo BA, Liao KP, Giordano SH, Elting LS, Shih YC. Variation in intensity and costs of care by payer and race for patients dying of cancer in Texas: an analysis of registry-linked Medicaid, Medicare, and dually eligible claims data. Med Care 53(7):591-8, 2015. PMID: 26067883.
181. Chavez-MacGregor M, Niu J, Zhang N, Elting LS, Smith BD, Banchs J, Hortobagyi GN, Giordano SH. Cardiac monitoring during adjuvant trastuzumab-based chemotherapy among older patients with breast cancer. J Clin Oncol 33(19):2176-83, 2015. e-Pub 2015. PMID: 25964256.
182. Mitri ZI, Jackson M, Garby C, Song J, Giordano SH, Hortobágyi GN, Singletary CN, Hashmi SS, Arun BK, Litton JK. BRCAPRO 6.0 model validation in male patients presenting for BRCA testing. Oncologist 20(6):593-7, 2015. e-Pub 2015. PMID: 25948675.
183. Smith GL, Jiang J, Giordano SH, Meyer LA, Eifel PJ. Trends in the quality of treatment for patients with intact cervical cancer in the United States, 1999 through 2011. Int J Radiat Oncol Biol Phys 92(2):260-7, 2015. PMID: 25968823.
184. Gomez DR, Liao KP, Swisher SG, Blumenschein GR, Erasmus JJ, Buchholz TA, Giordano SH, Smith BD. Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival. Radiother Oncol 115(2):257-63, 2015. e-Pub 2015. PMID: 26013292.
185. Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz M, Goldstein LJ, Hudis CA, Isakoff SJ, Marcom PK, Mayer IA, McCormick B, Moran M, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Smith KL, Smith ML, Soliman H, Somlo G, Telli M, Ward JH, Shead DA, Kumar R. Breast cancer version 2.2015. J Natl Compr Canc Netw 13(4):448-75, 2015. PMID: 25870381.
186. Giordano SH. Comparative effectiveness research in cancer with observational data. Am Soc Clin Oncol Educ Book 35:e330-5, 2015. PMID: 25993193.
187. Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen C, Van't Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Breast 23(5):489-502, 2014. e-Pub 2014. PMID: 25244983.
188. Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen C, Van't Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) . Ann Oncol 25(10):1871-88, 2014. e-Pub 2014. PMID: 25234545.
189. Hoffman KE, Niu J, Shen Y, Jiang J, Davis JW, Kim J, Kuban DA, Perkins GH, Shah JB, Smith GL, Volk RJ, Buchholz TA, Giordano SH, Smith BD. Physician variation in management of low-risk prostate cancer: A population-based cohort study. JAMA Intern Med 174(9):1450-9, 2014. e-Pub 2014. PMID: 25023650.
190. Murthy RK, Varma A, Mishra P, Hess KR, Young E, Murray JL, Koenig KH, Moulder SL, Melhem-Bertrandt A, Giordano SH, Booser D, Valero V, Hortobagyi GN, Esteva FJ. Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancer. Cancer 120(13):1932-8, 2014. e-Pub 2014. PMID: 24677057.
191. Guadagnolo BA, Liao KP, Giordano SH, Elting LS, Buchholz TA, Shih YC. Increasing use of advanced radiation therapy technologies in the last 30 days of life among patients dying as a result of cancer in the United States. J Oncol Pract 10(4):e269-76, 2014. e-Pub 2014. PMID: 24756144.
192. Burstein HJ, Temin S, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Rowden D, Solky AJ, Stearns V, Winer EP, Griggs JJ. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology Clinical practice guideline focused update. J Clin Oncol 32(21):2255-69, 2014. e-Pub 2014. PMID: 24868023.
193. Barcenas CH, Niu J, Zhang N, Zhang Y, Buchholz TA, Elting LS, Hortobagyi GN, Smith BD, Giordano SH. Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer. J Clin Oncol 32(19):2010-7, 2014. e-Pub 2014. PMID: 24868022.
194. Ramakrishna N, Temin S, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Giordano SH, Gonzalez-Angulo AM, Kirshner JJ, Krop I, Levinson J, Modi S, Patt DA, Perez EA, Perlmutter J, Winer EP, Lin NU. Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32(19):2100-8, 2014. e-Pub 2014. PMID: 24799487.
195. Giordano SH, Temin S, Kirshner JJ, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Gonzalez-Angulo AM, Krop I, Levinson J, Lin NU, Modi S, Patt DA, Perez EA, Perlmutter J, Ramakrishna N, Winer EP, American Society of Clinical Oncology. Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32(19):2078-99, 2014. e-Pub 2014. PMID: 24799465.
196. Eberth JM, Xu Y, Smith GL, Shen Y, Jiang J, Buchholz TA, Hunt KK, Black DM, Giordano SH, Whitman GJ, Yang W, Shen C, Elting L, Smith BD. Surgeon influence on use of needle biopsy in patients with breast cancer: A national Medicare study. J Clin Oncol 32(21):2206-16, 2014. e-Pub 2014. PMID: 24912900.
197. Gonzalez-Angulo AM, Akcakanat A, Liu S, Green MC, Murray JL, Chen H, Palla SL, Koenig KB, Brewster AM, Valero V, Ibrahim NK, Moulder-Thompson S, Litton JK, Tarco E, Moore J, Flores P, Crawford D, Dryden MJ, Symmans WF, Sahin A, Giordano SH, Pusztai L, Do KA, Mills GB, Hortobagyi GN, Meric-Bernstam F. Open label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC vs. the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer. Ann Oncol 25(6):1122-7, 2014. e-Pub 2014. PMID: 24669015.
198. Ost DE, Niu J, Elting LS, Buchholz TA, Giordano SH. Determinants of practice patterns and quality gaps in lung cancer staging and diagnosis. Chest 145(5):1097-1113, 2014. e-Pub 2013. PMID: 24202651.
199. Gradishar WJ, Anderson BO, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung BM, Marcom PK, Mayer IA, McCormick B, Miller RS, Pegram M, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Smith ML, Soliman H, Somlo G, Ward JH, Wolff AC, Zellars R, Shead DA, Kumar R. Breast cancer version 3.2014. J Natl Compr Canc Netw 12(4):542-90, 2014. PMID: 24717572.
200. Shih YC, Xu Y, Dong W, Smieliauskas F, Giordano S, Shen Y. First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer. Breast Cancer Res Treat 144(2):417-25, 2014. e-Pub 2014. PMID: 24557339.
201. Gagliato Dde M, Gonzalez-Angulo AM, Lei X, Theriault RL, Giordano SH, Valero V, Hortobagyi GN, Chavez-Macgregor M. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol 32(8):735-44, 2014. e-Pub 2014. PMID: 24470007.
202. Jagsi R, Jiang J, Momoh AO, Alderman A, Giordano SH, Buchholz TA, Kronowitz SJ, Smith BD. Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol 32(9):919-26, 2014. e-Pub 2014. PMID: 24550418.
203. Smith GL, Jiang J, Buchholz TA, Xu Y, Hoffman KE, Giordano SH, Hunt KK, Smith BD. Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: Impact of patient stratification on breast preservation. Int J Radiat Oncol Biol Phys 88(2):274-84, 2014. e-Pub 2013. PMID: 24268788.
204. Ost DE, Niu J, Elting LS, Buchholz TA, Giordano SH. Quality gaps and comparative effectiveness in lung cancer staging and diagnosis. Chest 145(2):331-45, 2014. e-Pub 2013. PMID: 24091637.
205. Chavez-MacGregor M, Zhang N, Buchholz TA, Zhang Y, Niu J, Elting L, Smith BD, Hortobagyi GN, Giordano SH. Trastuzumab-related cardiotoxicity among older patients with breast cancer. J Clin Oncol 31(33):4222-8, 2013. e-Pub 2013. PMID: 24127446.
206. Jiralerspong S, Kim ES, Dong W, Feng L, Hortobagyi GN, Giordano SH. Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol 24(10):2506-14, 2013. e-Pub 2013. PMID: 23793035.
207. Giordano SH. Lumpectomy in male patients with breast cancer. Ann Surg Oncol 20(8):2460-1, 2013. e-Pub 2013. PMID: 23689936.
208. Walker GV, Giordano SH, Williams M, Jiang J, Niu J, MacKinnon J, Anderson P, Wohler B, Sinclair AH, Boscoe FP, Schymura MJ, Buchholz TA, Smith BD. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. Int J Radiat Oncol Biol Phys 86(4):686-93, 2013. PMID: 23773392.
209. Theriault RL, Carlson RW, Allred C, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Schwartzberg LS, Smith ML, Soliman H, Somlo G, Ward JH, Wolff AC, Zellars R, Shead DA, Kumar R, National Comprehensive Cancer Network. Breast Cancer, Version 3.2013. J Natl Compr Canc Netw 11(7):753-761, 2013. PMID: 23847214.
210. Chavez-Macgregor M, Clarke CA, Lichtensztajn D, Hortobagyi GN, Giordano SH. Male breast cancer according to tumor subtype and race: A population based study. Cancer 119(9):1611-7, 2013. e-Pub 2013. PMID: 23341341.
211. Yi M, Cormier JN, Xing Y, Giordano SH, Chai C, Meric-Bernstam F, Vlastos G, Kuerer HM, Mirza NQ, Buchholz TA, Hunt KK. Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy. Ann Surg Oncol 20(5):1514-21, 2013. e-Pub 2012. PMID: 23224829.
212. Gomez DR, Liao KP, Giordano S, Nguyen H, Smith BD, Elting LS. Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer: A population-based study. Cancer 119(7):1428-36, 2013. e-Pub 2012. PMID: 23212885.
213. Ruddy KJ, Giobbie-Hurder A, Giordano SH, Goldfarb S, Kereakoglow S, Winer EP, Partridge AH. Quality of life and symptoms in male breast cancer survivors. Breast 22(2):197-9, 2013. e-Pub 2013. PMID: 23313328.
214. Shi Q, Giordano SH, Lu H, Saleeba AK, Malveaux D, Cleeland CS. Anastrozole-associated joint pain and other symptoms in patients with breast cancer. J Pain 14(3):290-6, 2013. PMID: 23452648.
215. Du XL, Parikh RC, Lairson DR, Giordano SH, Cen P. Comparative effectiveness of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer. Med Oncol 30(1):440, 2013. e-Pub 2013. PMID: 23307252.
216. Guadagnolo BA, Liao KP, Elting L, Giordano S, Buchholz TA, Shih YC. Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States. J Clin Oncol 31(1):80-7, 2013. e-Pub 2012. PMID: 23169520.
217. Chae YK, Brown EN, Lei X, Melhem-Bertrandt A, Giordano SH, Litton JK, Hortobagyi GN, Gonzalez-Angulo AM, Chavez-Macgregor M. Use of ACE inhibitors and angiotensin receptor blockers and primary breast cancer outcomes. J Cancer 4(7):549-56, 2013. e-Pub 2013. PMID: 23983819.
218. Rodriguez AM, Giordano SH, Cooksley CD. Utilization of BRCA testing in older women with breast and/or ovarian cancer in the state of Texas. Texas Public Health Journal 65(2):30-36, 2013.
219. Hoffman KE, Jiangong N, Giordano SH, Ho V, Smith, BD. Prostate cancer treatment patterns in the state of Texas, 2004-2007. Texas Public Health Journal 65(2):37-43, 2013.
220. Guadagnolo BA, Xu Y, Zagars GK, Cormier JN, Pollock RE, Feig BW, Giordano S, Buchholz TA, Shih YC. A population-based study of the quality of care in the diagnosis of large (≥5 cm) soft tissue sarcomas. Am J Clin Oncol 35(5):455-61, 2012. e-Pub 2011. PMID: 21537147.
221. Albert JM, Pan IW, Shih YC, Jiang J, Buchholz TA, Giordano SH, Smith BD. Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery. Cancer 118(19):4642-51, 2012. e-Pub 2012. PMID: 22890779.
222. Albert JM, Liu DD, Shen Y, Pan IW, Shih YC, Hoffman KE, Buchholz TA, Giordano SH, Smith BD. Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery. J Clin Oncol 30(23):2837-43, 2012. e-Pub 2012. PMID: 22734034.
223. Carlson RW, Allred DC, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Smith ML, Soliman H, Somlo G, Theriault RL, Ward JH, Wolff AC, Zellars R, Kumar R, Shead DA, National Comprehensive Cancer Network. Metastatic Breast Cancer, Version 1.2012: Featured Updates to the NCCN Guidelines. J Natl Compr Canc Netw 10(7):821-829, 2012. PMID: 22773798.
224. Pemmaraju N, Munsell MF, Hortobagyi GN, Giordano SH. Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects. Ann Oncol 23(6):1471-4, 2012. e-Pub 2011. PMID: 22085764.
225. Giordano SH, Lin YL, Kuo YF, Hortobagyi GN, Goodwin JS. Decline in the use of anthracyclines for breast cancer. J Clin Oncol 30(18):2232-9, 2012. e-Pub 2012. PMID: 22614988.
226. Moulder S, Gladish G, Ensor J, Gonzalez-Angulo AM, Cristofanilli M, Murray JL, Booser D, Giordano SH, Brewster A, Moore J, Rivera E, Hortobagyi GN, Tran HT. A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer. Cancer 118(9):2378-84, 2012. e-Pub 2011. PMID: 22006179.
227. Cheng L, Swartz MD, Zhao H, Kapadia AS, Lai D, Rowan PJ, Buchholz TA, Giordano SH. Hazard of recurrence among women after primary breast cancer treatment - A 10-year follow-up using data from SEER-Medicare. Cancer Epidemiol Biomarkers Prev 21(5):800-9, 2012. e-Pub 2012. PMID: 22426147.
228. Smith GL, Xu Y, Buchholz TA, Giordano SH, Jiang J, Shih YC, Smith BD. Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA 307(17):1827-37, 2012. PMID: 22550197.
229. Barcenas CH, Zhang N, Zhao H, Duan Z, Buchholz TA, Hortobagyi GN, Giordano SH. Anthracycline regimen adherence in older patients with early breast cancer. Oncologist 17(3):303-11, 2012. e-Pub 2012. PMID: 22371383.
230. Roundtree AK, Giordano SH, Price A, Suarez-Almazor ME. Problems in transition and quality of care: perspectives of breast cancer survivors. Support Care Cancer 19(12):1921-9, 2011. e-Pub 2010. PMID: 21140173.
231. Smith BD, Jiang J, McLaughlin SS, Hurria A, Smith GL, Giordano SH, Buchholz TA. Improvement in breast cancer outcomes over time: Are older women missing out?. J Clin Oncol 29(35):4647-53, 2011. e-Pub 2011. PMID: 22067407.
232. Chavez-Macgregor M, Zhao H, Kroll M, Fang S, Zhang N, Hortobagyi GN, Buchholz TA, Shih YC, Giordano SH. Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer. Ann Oncol 22(11):2394-402, 2011. e-Pub 2011. PMID: 21393379.
233. Shirvani SM, Pan IW, Buchholz TA, Shih YC, Hoffman KE, Giordano SH, Smith BD. Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women. Cancer 117(20):4595-605, 2011. e-Pub 2011. PMID: 21710653.
234. Chavez-MacGregor M, Zhao H, Fang S, Srokowski TP, Hortobagyi GN, Giordano SH. Complications associated with erythropoietin-stimulating agents in patients with metastatic breast cancer: A Surveillance, Epidemiology, and End Results-Medicare Study. Cancer 117(16):3641-9, 2011. e-Pub 2011. PMID: 21656514.
235. Smith BD, Pan IW, Shih YC, Smith GL, Harris JR, Punglia R, Pierce LJ, Jagsi R, Hayman JA, Giordano SH, Buchholz TA. Adoption of intensity modulated radiation therapy for breast cancer in the United States. J Natl Cancer Inst 103(10):798-809, 2011. e-Pub 2011. PMID: 21525437.
236. Goodwin JS, Asrabadi A, Howrey B, Giordano S, Kuo YF. Multiple measurement of serum lipids in the elderly. Med Care 49(2):225-30, 2011. e-Pub 2010. PMID: 21150795.
237. Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Sachdev J, Smith ML, Somlo G, Ward JH, Wolff AC, Zellars R. Invasive breast cancer. J Natl Compr Canc Netw 9(2):136-222, 2011. PMID: 21310842.
238. Smith GL, Xu Y, Buchholz TA, Smith BD, Giordano SH, Haffty BG, Vicini FA, White JR, Arthur DW, Harris JR, Shih YC. Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care. J Clin Oncol 29(2):157-65, 2011. e-Pub 2010. PMID: 21135274.
239. La Vecchia C, Giordano SH, Hortobagyi GN, Chabner B. Overweight, obesity, diabetes, and risk of breast cancer: Interlocking pieces of the puzzle. Oncologist 16(6):726-9, 2011. e-Pub 2011. PMID: 21632448.
240. Dawood S, Broglio K, Ensor J, Hortobagyi GN, Giordano SH. Survival differences among women with de novo stage IV and relapsed breast cancer. Ann Oncol 21(11):2169-2174, 2010. e-Pub 2010. PMID: 20427349.
241. Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Ljung BM, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Smith ML, Somlo G, Topham NS, Ward JH, Winer EP, Wolff AC. Breast cancer: noninvasive and special situations. J Natl Compr Canc Netw 8(10):1182-207, 2010. PMID: 20971842.
242. Yi M, Giordano SH, Meric-Bernstam F, Mittendorf EA, Kuerer HM, Hwang RF, Bedrosian I, Rourke L, Hunt KK. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol 17(Suppl 3)(Suppl 3):343-51, 2010. e-Pub 2010. PMID: 20853057.
243. Chavez-Macgregor M, Litton J, Chen H, Giordano SH, Hudis CA, Wolff AC, Valero V, Hortobagyi GN, Bondy ML, Gonzalez-Angulo AM. Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity. Cancer 116(17):4168-77, 2010. e-Pub 2010. PMID: 20564153.
244. Burstein HJ, Prestrud AA, Seidenfeld J, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Malin J, Mamounas EP, Rowden D, Solky AJ, Sowers MR, Stearns V, Winer EP, Somerfield MR, Griggs JJ, American Society of Clinical Oncology. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol 28(23):3784-96, 2010. e-Pub 2010. PMID: 20625130.
245. Smith GL, Shih YC, Xu Y, Giordano SH, Smith BD, Perkins GH, Tereffe W, Woodward WA, Buchholz TA. Racial disparities in the use of radiation therapy following breast conserving surgery: a national Medicare study. Cancer 116(3):734-741, 2010. e-Pub 2009. PMID: 20014181.
246. Dawood S, Broglio K, Buzdar AU, Hortobagyi GN, Giordano SH. Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. J Clin Oncol 28(1):92-8, 2010. e-Pub 2009. PMID: 19933921.
247. Smith GL, Shih YC, Giordano SH, Smith BD, Buchholz TA. A method to predict breast cancer stage using medicare claims. Epidemiol Perspect Innov 7(1):1-9, 2010. e-Pub 2010. PMID: 20145734.
248. Korde LA, Zujewski JA, Kamin L, Giordano S, Domchek S, Anderson WF, Bartlett JM, Gelmon K, Nahleh Z, Bergh J, Cutuli B, Pruneri G, McCaskill-Stevens W, Gralow J, Hortobagyi G, Cardoso F. Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol 28(12):2114-22, 2010. e-Pub 2010. PMID: 20308661.
249. Raji MA, Tamborello LP, Kuo YF, Ju H, Freeman JL, Zhang DD, Giordano SH, Goodwin JS. Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer. Med Oncol 26(4):452-9, 2009. e-Pub 2008. PMID: 19067255.
250. Rao G, Giordano SH, Liu J, McCutcheon IE. The association of breast cancer and meningioma in men and women. Neurosurgery 65(3):483-9; discussion 489, 2009. PMID: 19687693.
251. Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung MC, Hortobagyi GN, Gonzalez-Angulo AM. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 27(20):3297-302. e-Pub 2009. PMID: 19487376.
252. Elting LS, Cooksley CD, Bekele BN, Giordano SH, Shih YC, Lovell KK, Avritscher EB, Theriault R. Mammography capacity impact on screening rates and breast cancer stage at diagnosis. Am J Prev Med 37(2):102-8. e-Pub 2009. PMID: 19524392.
253. Shen Y, Dong W, Feig BW, Ravdin P, Theriault RL, Giordano SH. Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004. Cancer 115(10):2041-51, 2009. e-Pub 2009. PMID: 19288569.
254. Srokowski TP, Fang S, Hortobagyi GN, Giordano SH. Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol 27(13):2170-6. e-Pub 2009. PMID: 19307509.
255. Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, Perkins GH, Elting LS. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 27(12):2007-14. e-Pub 2009. PMID: 19289624.
256. Dawood S, Broglio K, Kau SW, Green MC, Giordano SH, Meric-Bernstam F, Buchholz TA, Albarracin C, Yang WT, Hennessy BT, Hortobagyi GN, Gonzalez-Angulo AM. Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes. J Clin Oncol 27(2):220-6, 2009. e-Pub 2008. PMID: 19047281.
257. Smith GL, Xu Y, Shih YCT, Giordano SH, Smith BD, Hunt KK, Strom EA, Perkins GH, Hortobagyi GN, Buchholz TA. Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. J Am Coll Surg 209(4):425-433.e2, 2009. e-Pub 2009. PMID: 19801315.
258. Smith GL, Smith BD, Buchholz TA, Giordano SH, Garden AS, Woodward WA, Krumholz HM, Weber RS, Ang KK, Rosenthal DI. Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. J Clin Oncol 26(31):5119-25, 2008. e-Pub 2008. PMID: 18725647.
259. Dawood S, Broglio K, Gonzalez-Angulo AM, Buzdar AU, Hortobagyi GN, Giordano SH. Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer. J Clin Oncol 26(30):4891-8, 2008. e-Pub 2008. PMID: 18725649.
260. Srokowski TP, Fang S, Duan Z, Buchholz TA, Hortobagyi GN, Goodwin JS, Giordano SH. Completion of adjuvant radiation therapy among women with breast cancer. Cancer 13(1):494-502, 2008. PMID: 18442124.
261. Buchholz TA, Woodward WA, Duan Z, Fang S, Oh JL, Tereffe W, Strom EA, Perkins GH, Yu TK, Hunt KK, Meric-Bernstam F, Hortobagyi GN, Giordano SH. Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes. Int J Radiat Oncol Biol Phys 71(4):1022-7, 2008. e-Pub 2008. PMID: 18234447.
262. Giordano SH, Kuo YF, Duan Z, Hortobagyi GN, Freeman J, Goodwin JS. Limits of observational data in determining outcomes from cancer therapy. Cancer 112(11):2456-2466, 2008. PMID: 18428196.
263. Giordano SH, Fang S, Duan Z, Kuo YF, Hortobagyi GN, Goodwin JS. Use of intravenous bisphosphonates in older women with breast cancer. Oncologist 13(5):494-502, 2008. PMID: 18515734.
264. Wang FW, Uretsky BF, Freeman JL, Zhang D, Giordano SH, Goodwin JS. Survival advantage in medicare patients receiving drug-eluting stents compared with bare metal stents: Real or artefactual?. Catheter Cardiovasc Interv 71(5):644-5, 2008. PMID: 18360856.
265. Elting LS, Lu C, Escalante CP, Giordano SH, Trent J, Cooksley C, Avritscher EBC, Shih YCT, Ensor J, Bekele BN, Gralla R, Talcott JA, Rolston K. Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol 26(4):606-11, 2008. PMID: 18235119.
266. Smith GL, Smith BD, Giordano SH, Shih YCT, Woodward WA, Strom EA, Perkins GH, Tereffe W, Yu TK, Buchholz TA. Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer 112(6):1371-9, 2008. PMID: 18213620.
267. Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi GN, Babiera G. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 26(15):2482-8, 2008. PMID: 18427152.
268. Patt DA, Duan Z, Fang S, Hortobagyi GN, Giordano SH. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk. J Clin Oncol 25(25):3871-6. e-Pub 2007. PMID: 17664457.
269. Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, Rouzier R, Broglio K, Hortobagyi GN, Valero V. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. J Clin Oncol 25(31):4952-60, 2007. PMID: 17971593.
270. Luo R, Giordano SH, Zhang DD, Freeman J, Goodwin JS. The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist. Cancer 109(5):975-82, 2007. PMID: 17265530.
271. Pinder MC, Duan Z, Goodwin JS, Hortobagyi GN, Giordano SH. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 25(25):3808-15, 2007. e-Pub 2007. PMID: 17664460.
272. Gonzalez-Angulo AM, Hennessy BT, Broglio K, Meric-Bernstam F, Cristofanilli M, Giordano SH, Buchholz TA, Sahin A, Singletary SE, Buzdar AU, Hortobagyi GN. Trends for inflammatory breast cancer: is survival improving?. Oncologist 12(8):904-12, 2007. PMID: 17766649.
273. Wildiers H, Kunkler I, Biganzoli L, Fracheboud J, Vlastos G, Bernard C, Hurria A, Extermann M, Girre V, Brain E, Audisio R, Bartelink H, Barton M, Giordano S, Muss H, Aapro M. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 8(12):1101-15, 2007. PMID: 18054880.
274. Giordano SH, Duan Z, Kuo YF, Hortobagyi GN, Freeman J, Goodwin JS. Impact of a scientific presentation on community treatment patterns for primary breast cancer. J Natl Cancer Inst 98(6):382-8, 2006. PMID: 16537830.
275. Boughey JC, Bedrosian I, Meric-Bernstam F, Ross MI, Kuerer HM, Akins JS, Giordano SH, Babiera GV, Ames FC, Hunt KK. Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg 203(4):475-80, 2006. e-Pub 2006. PMID: 17000390.
276. Giordano SH, Duan Z, Kuo YF, Hortobagyi GN, Goodwin JS. Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol 24(18):2750-6, 2006. PMID: 16782915.
277. Giordano SH, Lee A, Kuo YF, Freeman J, Goodwin JS. Late gastrointestinal toxicity after radiation for prostate cancer. Cancer 107(2):423-32, 2006. PMID: 16779795.
278. Luo R, Giordano SH, Freeman JL, Zhang D, Goodwin JS. Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer. Oncologist 11(9):1025-33, 2006. PMID: 17030645.
279. Oh JL, Dryden MJ, Woodward WA, Yu TK, Tereffe W, Strom EA, Perkins GH, Middleton L, Hunt KK, Giordano SH, Oswald MJ, Domain D, Buchholz TA. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. J Clin Oncol 24(31):4971-5, 2006. PMID: 17075114.
280. Woodward WA, Giordano SH, Duan Z, Hortobagyi GN, Buchholz TA. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke. Cancer 106(12):2556-62, 2006. PMID: 16691617.
281. Patt D, Gauthier AM, Giordano SH. Paclitaxel in breast cancer. Women's Health 2(1):11-21, 2006.
282. Hennessy BT, Giordano SH, Broglio K, Duan Z, Trent J, Buchholz T, Babiera G, Hortobagyi G, Valero V. Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann Oncol 17(4):605-13, 2006. e-Pub 2006. PMID: 16469754.
283. Buzdar AU, Ibrahim NK, Francis D, Booser DJ, Thomas ES, Theriault RL, Pusztai L, Green MC, Arun BK, Giordano SH, Cristofanilli M, Frye DK, Smith TL, Hunt KK, Singletary SE, Sahin AA, Ewer MS, Buchholz TA, Berry D, Hortobagyi GN. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol 23(16):3676-85, 2005. e-Pub 2005. PMID: 15738535.
284. Du XL, Chan W, Giordano S, Geraci JM, Delclos GL, Burau K, Fang S. Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity. Cancer 104(5):913-24, 2005. PMID: 15991239.
285. Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist 10(7):471-9, 2005. PMID: 16079314.
286. Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML. Breast cancer treatment guidelines in older women. J Clin Oncol 23(4):783-91, 2005. PMID: 15681522.
287. Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97(6):419-24, 2005. PMID: 15770005.
288. Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, Hortobagyi GN. Adjuvant systemic therapy for male breast carcinoma. Cancer 104(11):2359-64, 2005. PMID: 16270318.
289. Hennessy BT, Krishnamurthy S, Giordano S, Buchholz TA, Kau SW, Duan Z, Valero V, Hortobagyi GN. Squamous cell carcinoma of the breast. J Clin Oncol 23(31):7827-35, 2005. PMID: 16258085.
290. Patt DA, Goodwin JS, Kuo YF, Freeman JL, Zhang DD, Buchholz TA, Hortobagyi GN, Giordano SH. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol 23(30):7475-82, 2005. e-Pub 2005. PMID: 16157933.
291. Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW, Ames FC, Kuerer HM. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200(4):516-26, 2005. PMID: 15804465.
292. Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN. Is breast cancer survival improving?. Cancer 100(1):44-52, 2004. PMID: 14692023.
293. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer 101(1):51-7, 2004. PMID: 15221988.
294. Giordano SH. Update on locally advanced breast cancer. Oncologist 8(6):521-30, 2003. PMID: 14657530.
295. Giordano SH Hortobagyi GN. Inflammatory breast cancer: clinical progress and the main problems that must be addressed. Breast Cancer Res 5(6):284-8, 2003. e-Pub 2003. PMID: 14580242.
296. Giordano SH, Booser DJ, Murray JL, Ibrahim NK, Rahman ZU, Valero V, Theriault RL, Rosales MF, Rivera E, Frye D, Ewer M, Ordonez NG, Buzdar AU, Hortobagyi GN. A detailed evaluation of cardiac toxicity: A phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer. Clin Cancer Res 8(11):3360-8, 2002. PMID: 12429622.
297. Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med 137(8):678-87, 2002. PMID: 12379069.
298. Giordano SH, Valero V, Buzdar AU, Hortobagyi GN. Efficacy of anastrozole in male breast cancer. Am J Clin Oncol 25(3):235-7, 2002. PMID: 12040279.
299. Wehner MR, Niu J, Wheless L, Wang LX, Cohen OG, Margolis DJ, Giordano SH, Shin TM. Risk of multiple skin cancers in organ transplant recipients: A cohort study in two administrative datasets. JAMA Dermatol.
300. Navsaria L, Li Y, Nowakowska MK, Hinkston C, Wheless L, Giordano SH, Wehner MR. Incidence and treatments of actinic keratosis in the Medicare population: a cohort study. JAMA Dermatol.
301. Chavez Mac Gregor M, Malinowski C, Lei X, Zhao H, Giordano S. Impact of Medicaid expansion on mortality disparity among patients with de novo stage IV breast cancer (BC) according to race: A cross-sectional study. JAMA Oncol.

Invited Articles

1. Giordano SH. Trends in breast cancer survival for women with recurrent breast cancer. The American Journal of Oncology Review 3(6):330-339, 2004.

Editorials

1. Giordano SH. Radiotherapy in older women with low-risk breast cancer: Why did practice not change?. J Clin Oncol 30(14):1577-8, 2012. PMID: 22393087.
2. Giordano SH. Disparities in systemic therapy for breast cancer. J Clin Oncol Podcast, 2011.
3. Giordano SH. Commentary on breast cancer in men in the United States: A population-based study of diagnosis, treatment, and survival. Breast Diseases: A Year Book Quarterly 22(1):28-29, 2011.
4. Wang XS, Giordano S. Commentary on prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Breast Diseases: A Year Book Quarterly 22(3):257-258, 2011.
5. Dean-Colomb W, Giordano SH. Commentary on cancer treatment adherence among low-income women with breast or gynecologic cancer: A randomized controlled trial of patient navigation. Breast Diseases: A Year Book Quarterly 21(1):31, 2010.
6. Giordano SH, Hortobagyi GN. Time to remove the subspecialty blinders: breast cancer does not exist in isolation. J Natl Cancer Inst 100(4):230-1. PMID: 18270334.
7. Giordano S. Commentary on breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. Breast Diseases: A Year Book Quarterly 19(1):37-8, 2008.
8. Giordano SH. Male breast cancer: It's time for evidence instead of extrapolation. Onkologie 31(10):505-6, 2008. PMID: 18854647.
9. Giordano SH, Hortobagyi GN. Local recurrence or cardiovascular disease: pay now or later?. J Natl Cancer Inst 99(5):340-41, 2007. PMID: 17341720.
10. Patt DA, Giordano SH. Commentary on late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. Breast Diseases: A Year Book Quarterly 18(3):299, 2007.
11. Dawood S, Giordano SH. Review of male breast cancer during treatment with leuprolide for prostate cancer. Clinical Advances in Hematology & Oncology 5(7):556, 2007.
12. Giordano SH. Commentary on breast cancer with synchronous metastases: trends in survival during a 14 year period. Breast Disease: A Year Book Quarterly 16(1):76-77, 2005.
13. Giordano SH. Reexamining the benefits of postlumpectomy radiation in older women. The American Journal of Oncology Review 4(2):79-81, 2005.
14. Giordano SH. Breast carcinoma and antihypertensive therapy: Robbing Peter to pay Paul. CANCER 98(7):1334-6, 2003. PMID: 14508818.
15. Giordano SH. Commentary on are patients diagnosed with breast cancer before age 50 years ever cured?. Breast Diseases: A Year Book Quarterly 15(3), 2003.